We are live on
!
Find out more
PFM
Privium Fund Management Portfolio holdings
AUM
$480M
1-Year Est. Return
77.45%
This Fund
S&P 500
This Quarter
Est. Return
+42.32%
1 Year Est. Return
+77.45%
3 Year Est. Return
+410.34%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$556M
AUM Growth
+$92.8M
(+20%)
Cap. Flow
-$17.8M
Cap. Flow
% of AUM
-3.19%
Top 10 Holdings %
Top 10 Hldgs %
74.81%
Holding
63
New
8
Increased
21
Reduced
16
Closed
4
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
+$9.68M |
| 2 |
Lemonade
LMND
|
+$7.07M |
| 3 |
AST SpaceMobile
ASTS
|
+$5.3M |
| 4 |
Biogen
BIIB
|
+$4.25M |
| 5 |
Iris Energy
IREN
|
+$3.16M |
Top Sells
| 1 |
Palantir
PLTR
|
+$24.3M |
| 2 |
Spotify
SPOT
|
+$13.3M |
| 3 |
Sea Limited
SE
|
+$8.57M |
| 4 |
Arrowhead Research
ARWR
|
+$3.04M |
| 5 |
Shopify
SHOP
|
+$2.03M |
Sector Composition
| 1 | Consumer Discretionary | 30.53% |
| 2 | Healthcare | 25.52% |
| 3 | Technology | 23.08% |
| 4 | Communication Services | 11.92% |
| 5 | Financials | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABVX
26
Abivax
ABVX
$11.8B
| $2.58M | 0.46% |
+30,412
| New | +$1.86M |
|
|
RNAM
27
DELISTED
Avidity Biosciences
RNAM
| $2.31M | 0.42% |
53,000
+7,000
| +15% | +$283K |
|
28
Hims & Hers Health
HIMS
$8.14B
| $2.27M | 0.41% |
40,000
+18,000
| +82% | +$922K |
|
29
Krystal Biotech
KRYS
$10B
| $2.15M | 0.39% |
12,170
+2,850
| +31% | +$427K |
|
30
Ambev
ABEV
$47.7B
| $2M | 0.36% |
897,134
+101,348
| +13% | +$232K |
|
31
Roivant Sciences
ROIV
$25.1B
| $1.92M | 0.35% |
126,923
| – | – |
|
32
BioNTech
BNTX
$22.9B
| $1.87M | 0.34% |
19,000
+8,013
| +73% | +$857K |
|
33
4D Molecular Therapeutics
FDMT
$612M
| $1.72M | 0.31% |
197,458
| – | – |
|
34
Acadia Pharmaceuticals
ACAD
$4.36B
| $1.5M | 0.27% |
70,400
-78,000
| -53% | -$1.84M |
|
35
Beam Therapeutics
BEAM
$3.18B
| $1.48M | 0.27% |
+61,000
| New | +$1.21M |
|
36
Rocket Pharmaceuticals
RCKT
$397M
| $1.41M | 0.25% |
432,760
| – | – |
|
37
MeiraGTx Holdings
MGTX
$1.15B
| $1.34M | 0.24% |
163,000
| – | – |
|
38
Lexeo Therapeutics
LXEO
$363M
| $1.28M | 0.23% |
192,356
+14,000
| +8% | +$67.7K |
|
39
Wave Life Sciences
WVE
$1.18B
| $1.24M | 0.22% |
170,000
+34,450
| +25% | +$279K |
|
40
Moderna
MRNA
$26.8B
| $1.21M | 0.22% |
47,000
-56,433
| -55% | -$1.57M |
|
|
SA
41
Seabridge Gold
SA
$2.78B
| $1.17M | 0.21% |
48,474
+4,400
| +10% | +$76.1K |
|
42
Pfizer
PFE
$138B
| $962K | 0.17% |
37,750
+721
| +2% | +$17.8K |
|
43
ALX Oncology
ALXO
$269M
| $932K | 0.17% |
509,059
| – | – |
|
|
VZLA
44
Vizsla Silver
VZLA
$1.12B
| $884K | 0.16% |
204,654
-46,136
| -18% | -$160K |
|
45
NOV
NOV
$6.93B
| $846K | 0.15% |
63,876
| – | – |
|
46
Pan American Silver
PAAS
$18.3B
| $718K | 0.13% |
18,531
-11,216
| -38% | -$361K |
|
47
Sprott Uranium Miners ETF
URNM
$1.86B
| $692K | 0.12% |
11,448
-4,830
| -30% | -$243K |
|
48
SLB Ltd
SLB
$71.1B
| $677K | 0.12% |
+19,697
| New | +$685K |
|
49
Recursion Pharmaceuticals
RXRX
$1.77B
| $581K | 0.1% |
119,000
| – | – |
|
50
SandRidge Energy
SD
$506M
| $568K | 0.1% |
50,392
+13,370
| +36% | +$148K |
|
Similar funds
FCM
DA
YLHM
BFA
HC
LIM
TAA
NQWM